BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18228210)

  • 1. Clinical significance of metabolic superscan in patients with hyperthyroidism.
    Kotb MH; El-Maghraby T; Khalafallah K; Omar W; Grace BD; Al-Nahhas A
    Nucl Med Rev Cent East Eur; 2007; 10(2):76-81. PubMed ID: 18228210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.
    Erdil TY; Onsel C; Kanmaz B; Caner B; Sönmezoğlu K; Ciftçi I; Turoğlu T; Kabasakal L; Sayman HB; Uslu I
    J Nucl Med; 2000 Jul; 41(7):1163-7. PubMed ID: 10914905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperthyroidism, hypercalcemia and symmetrical and uniform increase in technetium 99m MDP uptake].
    Vaquer Arnau P; Ballester Oliver M; Siquier Mascaró B; Amengual Campins M
    Med Clin (Barc); 1989 Nov; 93(14):559. PubMed ID: 2622259
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of radionuclide imaging in hyperthyroid patients with no clinical suspicion of nodules.
    Lacey NA; Jones A; Clarke SE
    Br J Radiol; 2001 Jun; 74(882):486-9. PubMed ID: 11459726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism: an underappreciated cause of diffuse bone disease.
    Swislocki AL; Barnett CA; Darnell P; Noth RH
    Clin Nucl Med; 1998 Apr; 23(4):241-3. PubMed ID: 9554201
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
    Guo N; Yang K; Lin YS; Wang T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):267-70. PubMed ID: 24997818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
    Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
    Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
    Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased pertechnetate and radioiodine uptake in the thyroid gland with subacute thyroiditis and concurrent Graves' disease.
    Li L; Sun L; Yu S; Ma C
    Hell J Nucl Med; 2016; 19(1):49-52. PubMed ID: 26929941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between peak systolic velocity of the inferior thyroid artery and technetium-99m pertechnetate thyroid uptake in differentiating Graves' disease from thyroiditis.
    Malik SA; Choh NA; Misgar RA; Khan SH; Shah ZA; Rather TA; Shehjar F; Laway BA
    Arch Endocrinol Metab; 2019; 63(5):495-500. PubMed ID: 31482952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of pediatric hyperthyroidism: technetium 99 uptake versus thyroid stimulating immunoglobulins.
    Baskaran C; Misra M; Levitsky LL
    Thyroid; 2015 Jan; 25(1):37-42. PubMed ID: 25257665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m pertechnetate thyroid images in hyperthyroidism. Size, distribution, and presence of a pyramidal lobe.
    Spencer RP; Scholl RJ; Erbay N
    Clin Nucl Med; 1997 Aug; 22(8):519-22. PubMed ID: 9262895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
    Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methimazole on thyroid gland uptake of 99mTC-pertechnetate in 19 hyperthyroid cats.
    Fischetti AJ; Drost WT; DiBartola SP; Chew DJ; Schenck PA; Meadows C
    Vet Radiol Ultrasound; 2005; 46(3):267-72. PubMed ID: 16050288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
    Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
    J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.